AI주식인사이트AI Stock Insight
B

유나이티드제약

033270KOSPI

68.4 / 100

Reference Date: 2026-09-09

Financial Score29.5 / 40
News Sentiment17.9 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

United Pharmaceutical is a specialized generic drug manufacturer focusing on improved drugs, achieving sales of 2.887 trillion won in 2024 with a 20% operating profit margin through key products like Silostan CR Tablets and Artmax Combi Gel. The company maintains advanced production facilities and R&D capabilities, exporting pharmaceuticals to over 40 countries and launching 17 improved drug formulations.

Number of Employees

902people

Average Salary

67.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
6.97Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.64Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
8.90Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
3.76Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼4.7% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 10.2% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 4Neutral 2Negative 0Average Sentiment Score 71.7

Detailed Momentum

52-week position3.0Point

52w lower range (33%)

Current 18,230Won52-week high 21,40052-week low 16,600
1-month return3.0Point

1m -0.38% (flat)

Volume trend5.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral최대주주변경2026-08-11
  • Neutral주식등의대량보유상황보고서(일반)2026-08-11
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-11
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-11